A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)-Reference-Cited by-同舟云学术

A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE)

Published:2008-01 Issue:1 Volume:155 Page:113.e1-113.e8
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Jang Ik-Kyung,Weissman Neil J.,Picard Michael H.,Zile Michael R.,Pettigrew Veronica,Shen Steven,Tatsuno Jun,Hibberd Mark G.,Tzivoni Dan,Wackers Frans J. Th.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction;Montalescot;N Engl J Med,2001

2. Controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) investigators. Comparison of angioplasty with stenting with or without abciximab in acute myocardial infarction;Stone;N Engl J Med,2002

3. In-hospital and one-year outcomes for patients undergoing percutaneous coronary intervention for acute myocardial infarction;Shihara;Am J Cardiol,2002

4. Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries;Williams;Circulation,2000

5. Randomised placebo-controlled and balloon-angioplasty–controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade;The EPISTENT Investigators;Lancet,1998

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reperfusion injury in acute ischemic stroke: Tackling the irony of revascularization;Clinical Neurology and Neurosurgery;2023-02

2. Pharmacologic Prevention of Myocardial Ischemia–Reperfusion Injury in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention;Journal of Cardiovascular Pharmacology;2021-04

3. Reperfusion injury as a target for diminishing infarct size;Medical Hypotheses;2020-04

4. Electropharmacological effects of intracellular Ca2+ handling modulator caldaret on the heart assessed in the halothane-anesthetized dogs;Journal of Pharmacological Sciences;2019-03

5. Improving myocardial injury, infarct size, and myocardial salvage in the era of primary PCI for STEMI;Coronary Artery Disease;2015-06